SCHEMBL1685473

SCHEMBL1685473

CCCCNCCCC.CCCNCCC

nearest known ligand 0.69

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSHR P16473 3/20 0.69
ALDH1A1 P00352 1/20 0.69
CYP2C19 P33261 2/20 0.50
PAOX Q6QHF9 1/20 0.50
MEN1 O00255 1/20 0.50
GLA P06280 1/20 0.50
KMT2A Q03164 1/20 0.50
ADH1B P00325 3/20 0.48
ADH1A P07327 3/20 0.48
ADH7 P40394 3/20 0.48
ADH1C P00326 2/20 0.48
CYP1A2 P05177 1/20 0.47
CA12 O43570 1/20 0.41
CA1 P00915 1/20 0.41
CA2 P00918 1/20 0.41
CA7 P43166 1/20 0.41
CA14 Q9ULX7 1/20 0.41
S1PR2 O95136 5/20 0.41
S1PR4 O95977 5/20 0.41
S1PR1 P21453 5/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL74704 1.00
SCHEMBL5701105 0.97 TSHR (0.65) TSHRALDH1A1CYP2C19PAOXMEN1
SCHEMBL2856763 0.97 TSHR (0.65) TSHRALDH1A1CYP2C19PAOXMEN1
Hydrochloric Acid SCHEMBL22771814 0.97
SCHEMBL5701157 0.97 TSHR (0.65) TSHRALDH1A1CYP2C19PAOXMEN1
Ammonia Solution, Strong SCHEMBL11331652 0.97
SCHEMBL6733972 0.97 TSHR (0.65) TSHRALDH1A1CYP2C19PAOXMEN1
SCHEMBL18427255 0.97 TSHR (0.65) TSHRALDH1A1CYP2C19PAOXMEN1
Methyl Alcohol SCHEMBL28774680 0.94 TSHR (0.61) TSHRALDH1A1CYP2C19PAOXMEN1
SCHEMBL6764717 0.94 TSHR (0.81) TSHRALDH1A1CYP2C19PAOXMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 34 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240141095-A1 CURABLE RESIN COMPOSITION, CURED PRODUCT AND ADHESIVE ADEKA CORPORATION (JP) 2024-05-02 US disclosed
US-20240141094-A1 CURABLE RESIN COMPOSITION, CURED PRODUCT, AND ADHESIVE ADEKA CORPORATION (JP) 2024-05-02 US disclosed
EP-4361193-A1 EPOXY RESIN COMPOSITION ADEKA CORPORATION (JP) 2024-05-01 EP disclosed
WO-2024070902-A1 COMPOUND, METHOD FOR PRODUCING SAID COMPOUND, CURABLE MATERIAL, CURABLE COMPOSITION, METHOD FOR PRODUCING CURED ARTICLE, AND CURED ARTICLE 株式会社ADEKA 2024-04-04 WO disclosed
US-20240109869-A1 CHARGE TRANSFER COMPLEX ADEKA CORPORATION (JP) 2024-04-04 US disclosed
EP-4339220-A1 CURABLE COMPOSITION, CURED OBJECT, FIBER-REINFORCED COMPOSITE MATERIAL, AND MOLDED FIBER-REINFORCED RESIN ARTICLE DIC Corporation (JP) 2024-03-20 EP disclosed
US-20240084065-A1 NOVEL COMPOUND, AND CURABLE RESIN COMPOSITION CONTAINING SAID COMPOUND ADEKA CORPORATION (JP) 2024-03-14 US disclosed
EP-4306566-A1 CURABLE RESIN COMPOSITION, CURED PRODUCT AND ADHESIVE ADEKA CORPORATION (JP) 2024-01-17 EP disclosed
EP-4306567-A1 CURABLE RESIN COMPOSITION, CURED PRODUCT, AND ADHESIVE ADEKA CORPORATION (JP) 2024-01-17 EP disclosed
EP-4289837-A1 NOVEL COMPOUND, AND CURABLE RESIN COMPOSITION CONTAINING SAID COMPOUND ADEKA CORPORATION (JP) 2023-12-13 EP disclosed
US-20220185946-A1 CURABLE RESIN COMPOSITION ADEKA CORPORATION (JP) 2022-06-16 US disclosed
EP-3950761-A1 CURABLE RESIN COMPOSITION ADEKA CORPORATION (JP) 2022-02-09 EP disclosed
US-20160108284-A1 POLISHING COMPOSITION FUJIMI INCORPORATED (JP) 2016-04-21 US disclosed
US-8911586-B2 One liquid type cyanate-epoxy composite resin composition ADEKA CORPORATION (JP) 2014-12-16 US disclosed
US-20110095453-A1 ONE LIQUID TYPE CYANATE-EPOXY COMPOSITE RESIN COMPOSITION ADEKA CORPORATION (JP) 2011-04-28 US disclosed
US-20100062188-A1 POLYIMIDE FILM HAVING SMOOTHNESS ON ONE SURFACE UBE INDUSTRIES, LTD. (JP) 2010-03-11 US disclosed
CN-1712135-A Production of dual-function base weak-base anion-exchange resin NANJING UNIVERSITY OF TECHNOLOGY (CN) 2005-12-28 CN disclosed
US-4327200-A Water-dilutable oxazolidine group containing epoxy resin esters, coating compositions prepared therefrom, and their use as cathodically depositable paints VIANOVA KUNSTHARZ, A.G. (AT) 1982-04-27 US disclosed
US-4301195-A HAVING INK RECEPTIVE STRATUM COMPRISING AN AMINIZED EPOXIDIZED RUBBERY POLYMER AND A VINYL ACETATE-VINYL ALCOHOL COPOLYMER MINNESOTA MINING AND MANUFACTURING COMPANY (US) 1981-11-17 US disclosed
US-4225652-A VINYL ACETATE-VINYL ALCOHOL COPOLYMER AND REACTION PRODUCT OF EPOXIDIZED RUBBERY POLYMER WITH A SECONDARY AMINE MINNESOTA MINING AND MANUFACTURING COMPANY (US) 1980-09-30 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240109869-A1 CHARGE TRANSFER COMPLEX TRMT1, ELP1, SEM1 TSHR 4611/4885ALDH1A1 1652/4885CYP2C19 2208/4885
US-20240084065-A1 NOVEL COMPOUND, AND CURABLE RESIN COMPOSITION CONTAINING SAID COMPOUND PSMC6, CAND1, RBX1 TSHR 4283/4885ALDH1A1 709/4885CYP2C19 2746/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.